Cimicifuga
Cimicifuga racemosa L.
Bibliografia
- [BHP]
- [Weiss]
- [Wren]1. Liske E (1998) Advances in Therapy; 15:45-53
- 2. Mahady, G.B.(2005) Treat Endocrinol, 2005, 4, 177-184
- 3. Stoll W. (1987) Therapeuticum.;1:23-31.
- 4. Liske E, Hanggi W, Eenneicke-von Zepplein EE et al (2002) J Womens Health Gender-Based Med 11:163-74
- 5. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinbe D et al (2001) J Clin Oncol. 19:2739
- 6. Wuttke W, Seidlova-Wuttke D, Gorkow C (2003) Maturitas; 44(Suppl 1):S59-S65
- 7. Wuttke W, Garkow C, Seidlova-Wuttke D (2006) Menopause 13:185-196
- 8. Schulz V. (2006) Zeitschrift fur Phytotherapie 2
- 9. Sammartino, A.; Tommaselli, G.; Gargano, V.; di Carlo, C.; Attianese, W. & Nappi, C. (2006) Gynecol Endocrinol, 22, 646-650
- 10. Uebelhack, R.; Blohmer, J.; Graubaum, H.; Busch, R.; Gruenwald, J. & Wernecke, K. (2006) Obstet Gynecol,, 107, 247-255
- 11. Pockaj BA, Gallagher JG, Loprinzi CL et al. (2006) J.Clin.Oncol., 24,2836-41s
- 12. Lehmann-Willenbrock E, Riedel HH (1988) Zentralbl Gynakol ;110(10):611-8
- 13. Hernandez Munoz G, Pluchino S (2003) Maturitas; 44 (Suppl):S67-S77
- 14. Gerhard I, Liske E, Wustenberg P (1995) Z Phytother Abstractband 21-22
- 15. Boblitz N et al (1995) Focus Alternat Complement Ther 5(1):85-86
- 16. Nesselhut T, Liske E (1999) Abstracts of 10th Annual Meeting od the North American Menopause Society (NAMS). New York, 23-25 settembre 1999 (abstr n 99.012)
- 17. Seidlova-Wuttke D,Wuttke W. (2000) Paper presented at the 3rd International Congress on Phytomedicine, Munich (SL-9a).
- 18. Seidlova-Wuttke D,Jarry H,Heiden I et al. (2000) Paper presented at the 3rd International Congress on Phytomedicine, Munich (SL-9b).
- 19. Wuttke W,Jarry H,Heiden I et al. (2000) Paper presented at the 3rd International Congress on Phytomedicine, Munich (SL-10).
- 20. Raus, K.; Brucker, C.; Gorkow, C. & Wuttke, W. (2006) Menopause, 2006, 13, 678-691
- 21. Dugoua, J.; Seely, D.; Perri, D.; Koren, G. & Mills, E. (2006) Can J Clin Pharmacol, 2006, 13, e257-e261
- 22. Workshop on the safety of Black Cohosh in clinical studies. National Center for complementary and alternative medicine and office of dietary supplements. National Institutes of Health. 22 novembre, 2004.
- 23. Therapeutic Goods Administration (2006) “Black cohosh (Cimicifuga racemosa). New labelling and consumer information for medicines containing Black cohosh (Cimicifuga racemosa).
- 25. [comunicato stampa]. Londra: European Medicines Agency. 18 luglio 2006. Documento numero: EMEA/269259/2006,
- 26. HMPC Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root) 18 luglio 2006. Documento numero: EMEA/HMPC/269259/2006
- 27. Cohen SM, O’Connor AM, Hart J, Merel NH, Te HS (2004) Menopause; 11(5):575-577
- 28. Lynch CR et al (2006) Liver transplantation 12:989-992
- 29. Levitsky J, Alli TA, Wisecarver J, Sorrell MF. (2005) Digestive Diseases and Sciences 50(3):538-539
- 30. ANMFIT. Fegato: farmaci più tossici delle erbe. [comunicato stampa]. Associazione Nazionale Medici Fitoterapeuti. 06-09-2006
- 31. McIntyre, M. EHPA Chairman. Comunicazione personale in e-mail datata 13-09-2006
- 32. [comunicato stampa]. American Botanical Council. Austin, Texas, USA, 20 Luglio 2006.
Glossario